Clinical Trial Update: Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating camrelizumab in combination with trastuzumab and chemotherapy in HER2-positive advanced colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Fudan University | Conditions: Colorectal Neoplasms, Intestinal Neoplasms | Phase 2 | Status: UNKNOWN